FREE EMBRYONIC DNA IN PLASMA AS A PREDICTOR OF SPONTANEOUS PREGNANCY LOSSES IN WOMEN WITH RECURRENT MISCARRIAGE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To reveal an association between the plasma levels of free embryonic DNA (feDNA) in the first trimester of pregnancy and recurrent miscarriage before 22 weeks’ gestation. Subjects and methods. A study group included 122 women with recurrent miscarriage and a control group comprised 103 pregnant women without obstetric and gynecological histories. The levels of feDNA (SRY and DYS-14 genes) were determined in the first trimester of pregnancy by real-time polymerase chain reaction. In 44 patients, the study was conducted over time at 6 to 20 weeks’ gestation at a 2-week interval. Results. There was a significant excess of feDNA levels in the women with recurrent miscarriage as compared to those with uncomplicated pregnancy (DYS-14, 1021.0±660.6 versus 172.4±56.8 copies/ml; p<0.01; SRY, 124.4±48.3 versus 45.3±21.6 copies/ml;p<0.01). The women with recurrent miscarriage were found to have the rise in DYS-14 and SRY levels at 6 to 20 weeks’ gestation, which was greater than those in the control group (p<0.05). Comparison of feDNA DYS-14 levels in the women whose pregnancy ended in spontaneous abortion before 22 weeks’ gestation versus in those who gave birth to full-term babies showed significant differences (1697.5±980.7 and 841.8±394.8 copies/ml, respectively; р<0.0001). The similar indicators for the SRY gene were 174.077±49.616 and 108.2±37.8 copies/ml (р<0.0001). Conclusion. In the pregnant woman, the plasma feDNA release up to the levels much greater than those in physiological pregnancy can serve as a predictor of spontaneous abortion before 22 weeks’ gestation.

Full Text

Restricted Access

About the authors

N. I FEDOROVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: natasha_fedorova@mail.ru

N. K TETRUASHVILI

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tetrauly@mail.ru

L. Z FAIZULLIN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: lfaizullin@mail.ru

V. N KARNAUKHOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

G. T SUKHIKH

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

References

  1. Avent N.D., Chitty L.S. Non-Invasive diagnosis of fetal sex. Utilising free fetal DNA and ultrasound // Prenat. Diagn. - 2006. - Vol. 26, № 7. - P. 598 - 603.
  2. Hall A., Bostanci A., Wright C.F. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications // Public Health Genomics. - 2010. - Vol. 13, № 4. -P. 246 - 255.
  3. Hill M., Taffinder S., Chitty L.S. et al. Incremental cost of noninvasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England // Prenat. Diagn. - 2011. - Vol. 31, № 3. - P. 267 - 255.
  4. Illanes S., Denbow M., Kailasam C. et al. Early detection of cell-free fetal DNA in maternal plasma // Early Hum. Dev. - 2007 -Vol. 83. - P. 563 - 566.
  5. Lo Y.M. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art // BJOG. - 2009. -Vol. 116, № 2. - P. 152 - 157.
  6. Lo Y.M.D., Corbetta N., Chamberlain P.F. et al. Presence of fetal DNA in maternal plasma and serum // Lancet. - 1997 -Vol. 350. - P. 485 - 487.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies